Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11403-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MELK antibody
- Antibody type
- Polyclonal
- Description
- MELK antibody (Cat. #11403-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references MELK is Required for G2/M Phase Progression in Cortical Progenitors: Insights from Rare ASD-Associated Variants.
Melk facilitates pulmonary artery smooth muscle cell proliferation and migration in pulmonary hypertension via modulation of YAP/TAZ signaling.
A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK.
Identification and validation of a novel apoptosis-related prognostic risk score model for lung adenocarcinoma.
Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer.
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.
Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
Zhao L, Li X, Yang K, Jiang M, Chen Z, Shao Y, Lu T, Zhang D, Wang L, Li J
Cellular and molecular neurobiology 2026 Apr 13;46(1)
Cellular and molecular neurobiology 2026 Apr 13;46(1)
Melk facilitates pulmonary artery smooth muscle cell proliferation and migration in pulmonary hypertension via modulation of YAP/TAZ signaling.
Yang Q, Chen P, He X, Jian J, He M, Lin T, Zheng S, Liu D
Frontiers in cell and developmental biology 2025;13:1693346
Frontiers in cell and developmental biology 2025;13:1693346
A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK.
Ma Y, Cui Q, Zhu W, Wang M, Zhai L, Hu W, Liu D, Liu M, Li Y, Li M, Han W
Drug design, development and therapy 2024;18:1531-1546
Drug design, development and therapy 2024;18:1531-1546
Identification and validation of a novel apoptosis-related prognostic risk score model for lung adenocarcinoma.
Wang Y, Zhang J, Wan Y, Mi B, Li M, Xie X
Journal of Cancer 2024;15(11):3381-3393
Journal of Cancer 2024;15(11):3381-3393
Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer.
Su P, Yu T, Zhang Y, Huang H, Chen M, Cao C, Kang W, Liu Y, Yu J
Cancer cell international 2024 Aug 12;24(1):287
Cancer cell international 2024 Aug 12;24(1):287
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.
Ye J, Deng W, Zhong Y, Liu H, Guo B, Qin Z, Li P, Zhong X, Wang L
International journal of oncology 2022 Aug;61(2)
International journal of oncology 2022 Aug;61(2)
Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
Wu S, Chen X, Hu C, Wang J, Shen Y, Zhong Z
Medical science monitor : international medical journal of experimental and clinical research 2017 Dec 1;23:5705-5713
Medical science monitor : international medical journal of experimental and clinical research 2017 Dec 1;23:5705-5713
No comments: Submit comment
No validations: Submit validation data